Our pathogenesis model does not reject loss of microtubule integrity as a major pathological feature of advanced Alzheimer’s disease, but rather proposes that amyloidogenic APP processing may affect synaptic function by reducing the population of dynamic microtubules entering into synapses at an early stage of the disease. This evidence concerns the gene APP and Alzheimer disease.